explore -WSS

explore

author：comprehensive 2025-09-30 20:26:28 - browse：3125

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Organ aging and disease risk measured by new blood test

hotspot

WSS

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

CDC director unscathed in first congressional testimony

Malaysia cuts short music fest after British band slams anti

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

ReNAgade cuts staff seven months after raising $300 million

J&J to emphasize cancer drugs, stop much of its vaccine research

hotspot

explore

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Statins reduce cardiovascular risk in people living with HIV

Sports medicine is finally prioritizing gender equality

4 missing after record

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Transgender women dream of pregnancy via uterus transplants

How one medical school became remarkably diverse

New requirements coming in 2024 for Americans traveling to Europe

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Thousands protest mob assault of women who were paraded naked in remote Indian border state

explore

Clinic falsely told dozens they had Alzheimer's, suits say

Organ aging and disease risk measured by new blood test

Severe heat forecast: Where scorching temperatures will persist over the next week

PrEP can help anyone prevent HIV. Why do so few people take it?

Inside the culture of fear in the White House science office of Eric Lander

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

focus

hotspot

Wikipedia

leisure time